63 related articles for article (PubMed ID: 16638116)
1. Plasma resistin concentration, and steatosis and insulin sensitivity in hepatitis C virus-infected patients.
Petit JM; Minello A; Brisard C; Galland F; Duvillard L; Verges B; Hillon P
J Gastroenterol Hepatol; 2006 Mar; 21(3):624. PubMed ID: 16638116
[No Abstract] [Full Text] [Related]
2. Serum levels of adipokines in patients with chronic HCV infection: relationship with steatosis and fibrosis.
Tiftikci A; Atug O; Yilmaz Y; Eren F; Ozdemir FT; Yapali S; Ozdogan O; Celikel CA; Imeryuz N; Tozun N
Arch Med Res; 2009 May; 40(4):294-8. PubMed ID: 19608019
[TBL] [Abstract][Full Text] [Related]
3. Glucose intolerance and hypoadiponectinemia are already present in lean patients with chronic hepatitis C infected with genotype non-3 viruses.
Anty R; Gelsi E; Giudicelli J; Mariné-Barjoan E; Gual P; Benzaken S; Saint-Paul MC; Sadoul JL; Huet PM; Tran A
Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):671-7. PubMed ID: 17625437
[TBL] [Abstract][Full Text] [Related]
4. High serum resistin in chronic viral hepatitis is not a marker of metabolic disorder.
Morace C; Spadaro A; Cucunato M; Tortorella V; Consolo P; Luigiano C; Stabile G; Bonfiglio C; Bellerone R; Fortiguerra A; Alibrandi A; Crinò S; Carducci A; Resta ML; Ferraù O; Freni MA
Hepatogastroenterology; 2010; 57(102-103):1215-9. PubMed ID: 21410061
[TBL] [Abstract][Full Text] [Related]
5. Impact of steatosis on insulin secretion in chronic hepatitis C patients.
Narita R; Abe S; Tabaru A; Otsuki M
Am J Gastroenterol; 2007 Oct; 102(10):2173-80. PubMed ID: 17680843
[TBL] [Abstract][Full Text] [Related]
6. Serum adipokine levels in chronic liver diseases: association of resistin levels with fibrosis severity.
Tsochatzis E; Papatheodoridis GV; Hadziyannis E; Georgiou A; Kafiri G; Tiniakos DG; Manesis EK; Archimandritis AJ
Scand J Gastroenterol; 2008; 43(9):1128-36. PubMed ID: 18609175
[TBL] [Abstract][Full Text] [Related]
7. Hepatic steatosis and insulin resistance are associated with serum imbalance of adiponectin/tumour necrosis factor-alpha in chronic hepatitis C patients.
Durante-Mangoni E; Zampino R; Marrone A; Tripodi MF; Rinaldi L; Restivo L; Cioffi M; Ruggiero G; Adinolfi LE
Aliment Pharmacol Ther; 2006 Nov; 24(9):1349-57. PubMed ID: 17059516
[TBL] [Abstract][Full Text] [Related]
8. Elevated plasma resistin concentrations in patients with liver cirrhosis.
Kakizaki S; Sohara N; Yamazaki Y; Horiguchi N; Kanda D; Kabeya K; Katakai K; Sato K; Takagi H; Mori M
J Gastroenterol Hepatol; 2008 Jan; 23(1):73-7. PubMed ID: 18171344
[TBL] [Abstract][Full Text] [Related]
9. A link between leptin and steatosis in chronic hepatitis C? Time to weigh up the fats.
Patel K; Muir A; McHutchison JG; Patton HM
Am J Gastroenterol; 2003 May; 98(5):952-5. PubMed ID: 12809813
[No Abstract] [Full Text] [Related]
10. Plasma resistin is increased in patients with unstable angina.
Hu WL; Qiao SB; Hou Q; Yuan JS
Chin Med J (Engl); 2007 May; 120(10):871-5. PubMed ID: 17543176
[TBL] [Abstract][Full Text] [Related]
11. Hepatic steatosis in chronic hepatitis B develops due to host metabolic factors: a comparative approach with genotype 1 chronic hepatitis C.
Tsochatzis E; Papatheodoridis GV; Manesis EK; Chrysanthos N; Kafiri G; Archimandritis AJ
Dig Liver Dis; 2007 Oct; 39(10):936-42. PubMed ID: 17720637
[TBL] [Abstract][Full Text] [Related]
12. Review of patients with hepatosteatosis and chronic hepatitis C.
Smoliński P; Pazgan-Simon M; Zuwała-Jagiełło J; Hałoń A; Rotter K; Gładysz A
Przegl Epidemiol; 2008; 62(3):571-9. PubMed ID: 19108521
[TBL] [Abstract][Full Text] [Related]
13. Resistin serum levels are associated with insulin resistance, disease severity, clinical complications, and prognosis in patients with chronic liver diseases.
Yagmur E; Trautwein C; Gressner AM; Tacke F
Am J Gastroenterol; 2006 Jun; 101(6):1244-52. PubMed ID: 16771945
[TBL] [Abstract][Full Text] [Related]
14. Steatosis in chronic hepatitis C: relationship to the virus and host risk factors.
Matos CA; Perez RM; Pacheco MS; Figueiredo-Mendes CG; Lopes-Neto E; Oliveira EB; Lanzoni VP; Silva AE; Ferraz ML
J Gastroenterol Hepatol; 2006 Aug; 21(8):1236-9. PubMed ID: 16872303
[TBL] [Abstract][Full Text] [Related]
15. Elevated serum levels of caspase-cleaved cytokeratin 18 (CK18-Asp396) in patients with nonalcoholic steatohepatitis and chronic hepatitis C.
Yilmaz Y; Dolar E; Ulukaya E; Akgoz S; Keskin M; Kiyici M; Yerci O; Oral AY; Gul CB; Gurel S; Nak SG; Gulten M
Med Sci Monit; 2009 Apr; 15(4):CR189-93. PubMed ID: 19333204
[TBL] [Abstract][Full Text] [Related]
16. Hepatic steatosis and fibrosis in young men with treatment-naïve chronic hepatitis B.
Yun JW; Cho YK; Park JH; Kim HJ; Park DI; Sohn CI; Jeon WK; Kim BI; Son BH; Shin JH
Liver Int; 2009 Jul; 29(6):878-83. PubMed ID: 19192167
[TBL] [Abstract][Full Text] [Related]
17. Associations of resistin with inflammation and insulin resistance in patients with type 2 diabetes mellitus.
Mojiminiyi OA; Abdella NA
Scand J Clin Lab Invest; 2007; 67(2):215-25. PubMed ID: 17366001
[TBL] [Abstract][Full Text] [Related]
18. Adiponectin: a new independent predictor of liver steatosis and response to IFN-alpha treatment in chronic hepatitis C.
Zografos TA; Liaskos C; Rigopoulou EI; Togousidis E; Makaritsis K; Germenis A; Dalekos GN
Am J Gastroenterol; 2008 Mar; 103(3):605-14. PubMed ID: 18190648
[TBL] [Abstract][Full Text] [Related]
19. Liver microsomal triglyceride transfer protein is involved in hepatitis C liver steatosis.
Mirandola S; Realdon S; Iqbal J; Gerotto M; Dal Pero F; Bortoletto G; Marcolongo M; Vario A; Datz C; Hussain MM; Alberti A
Gastroenterology; 2006 May; 130(6):1661-9. PubMed ID: 16697730
[TBL] [Abstract][Full Text] [Related]
20. Gene expression of leptin, resistin, and adiponectin in the white adipose tissue of obese patients with non-alcoholic fatty liver disease and insulin resistance.
Baranova A; Gowder SJ; Schlauch K; Elariny H; Collantes R; Afendy A; Ong JP; Goodman Z; Chandhoke V; Younossi ZM
Obes Surg; 2006 Sep; 16(9):1118-25. PubMed ID: 16989692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
